Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in Adolescents

@article{Childress2012PharmacotherapyOA,
  title={Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in Adolescents},
  author={Ann C. Childress and Sally A. Berry},
  journal={Drugs},
  year={2012},
  volume={72},
  pages={309-325}
}
Attention-deficit hyperactivity disorder (ADHD) is a common neurobehavioural disorder in children and adolescents, consisting of developmentally inappropriate levels of inattention and/or hyperactivity and impulsivity. The majority of children with ADHD will continue to experience significant ADHD symptoms as teens. ADHD in adolescents can result in significant functional impairment and poorer quality of life. Children and adolescents with ADHD are at higher risk of developing other psychiatric… 
Treatment of Attention-Deficit Hyperactivity Disorder in Children and Adolescents: Benefits and Challenges
TLDR
A detailed review of the available literature suggests that there is an urgent need to conduct well-designed, longterm studies to more clearly understand the benefits and adverse effects associated with stimulant and non-stimulant use in the treatment of ADHD in children and adolescents.
PHARMACOLOGICAL TREATMENT IN STABILIZING THE SYMPTOMS IN CHILDREN WITH ADHD SYMPTOMS
Attention-deficit/hyperactivity disorder (ADHD) is a chronic disorder characterized by problems with paying attention, impulsivity and over-activity which influence all the life fields of a child
ADHD (ATTENTION DEFFICIT HYPERACTIVITY DISORDER)--A TROUBLING ENTITY, SOMETIMES PERPETUATING DURING ADULT LIFE.
TLDR
Management of ADHD is including behavioral therapies and medication, alone or combined, and Stimulant medications such as amphetamine represent the therapy of choice, being effective in 80% of the cases.
Attention-Deficit Hyperactivity Disorder (ADHD) in Children: A Movetowards Developmental Perspectives
The debate about diagnoses and treatment of attention deficit hyperactive disorder (ADHD) in children continue to range on between the developmental and biological perspectives. While there is
A Developmental Perspective to Attention-Deficit Hyperactivity Disorder (ADHD) in Children
The debate about diagnoses and treatment of attention deficit hyperactive disorder (ADHD) in children continue to range on between the developmental and biological perspectives. While there is
Hormone disorder and vitamin deficiency in attention deficit hyperactivity disorder (ADHD) and autism spectrum disorders (ASDs)
TLDR
The study results highlight the importance of supplementation of vitamins B12 and D in the ASD and ADHD patients and suggest that vitamin D levels of the ADHD group were significantly lower compared to the healthy controls.
A Review of the Pathophysiology, Etiology, and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD)
TLDR
This review focuses on the pathophysiology, etiology, and treatment of ADHD and details the adverse effects and drug interaction profiles of the drugs used to treat it.
Association of Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorders with Mean Platelet Volume and Vitamin D
TLDR
Both ADHD and ASDs may accompany increased risk for cardiovascular disease due to the presence of vitamin B12 and D deficiency and their own characteristics, therefore, these disorders should be closely followed up.
The effects of physical activity on children diagnosed with attention deficit hyperactivity disorder: a review
Attention deficit hyperactivity disorder (ADHD) is the most common neurodevelopmental psychiatric disorder among children. Despite the noted positive aspects of the disorder, it is often associated
Is high prevalence of vitamin D deficiency a correlate for attention deficit hyperactivity disorder?
TLDR
The study found significant association between ADHD and vitamin D deficiency after adjusting for BMI and sex and Vitamin D deficiency was higher in ADHD children compared to healthy children.
...
...

References

SHOWING 1-10 OF 77 REFERENCES
Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.
TLDR
The take-home message was that untreated ADHD was a significant risk factor for SUD in adolescence, but pharmacotherapy was associated with a significantly reduced risk.
Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression.
TLDR
ATX was an effective and safe treatment for ADHD in adolescents with ADHD and MDD, however, this trial showed no evidence for ATX of efficacy in treating MDD.
Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder.
  • R. Barkley
  • Psychology
    The Journal of clinical psychiatry
  • 2002
TLDR
Because most ADHD research has been conducted with male children and adolescents with ADHD, combined type, most outcomes for ADHD should be thought of as male outcomes for this subtype.
Stimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic outcome.
TLDR
Investigation of the relationship of childhood stimulant treatment to academic functioning during adolescence indicates that psychostimulant treatment for children with ADHD may benefit long-term adolescent academic performance, although the extent of improvement is likely to vary as a function of multiple factors.
Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data
TLDR
Atomoxetine treatment significantly reduced ADHD symptoms in both ODD-comorbid and noncomor bid subjects to similar extents, indicating that the presence of comorbid symptoms of oppositionality does not affect clinical outcomes of treatment of ADHD with atomoxetines.
Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder.
TLDR
Results support consideration of atomoxetine for the treatment of ADHD in youths who have ADHD with comorbid anxiety disorder and a significant reduction in independently assessed anxiety symptoms.
Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations.
Do Stimulants Protect Against Psychiatric Disorders in Youth With ADHD? A 10-Year Follow-up Study
TLDR
Evidence is found that stimulant treatment decreases the risk for subsequent comorbid psychiatric disorders and academic failure in youth with ADHD.
Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
TLDR
In adolescents, once-daily OROS methylphenidate significantly reduced ADHD symptoms and was well tolerated using dosages up to 72 mg/d.
...
...